FDA recall, , Moderate risk
HCSC-Blood Center Plasma and Red Blood Cells
HCSC-Blood Center Plasma and Red Blood Cells, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Recall ended Sep 24, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
HCSC-Blood Center recalled Red Blood Cells, Leukocytes Reduced, Irradiated; Red Blood Cells, Leukocytes Reduced; and PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, were distributed in Pennsylvania. The recall began June 5, 2025.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
3 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
PF24 Plasma
Reason: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- HCSC-Blood Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99048
- Recall numbers
- B-0206-2026 to B-0208-2026
All recalls from HCSC-Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
